BioLife Solutions, Inc. (BLFS)
NASDAQ: BLFS · Real-Time Price · USD
28.30
-0.19 (-0.67%)
Jan 29, 2025, 4:00 PM EST - Market closed
BioLife Solutions Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for BioLife Solutions stock have an average target of 29.43, with a low estimate of 22 and a high estimate of 33. The average target predicts an increase of 3.99% from the current stock price of 28.30.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for BLFS stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 6 | 6 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Northland Capital Markets | Northland Capital Markets | Buy Maintains $28 → $31 | Buy | Maintains | $28 → $31 | +9.54% | Jan 8, 2025 |
| Benchmark | Benchmark | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +6.01% | Dec 19, 2024 |
| Keybanc | Keybanc | Buy Maintains $30 → $33 | Buy | Maintains | $30 → $33 | +16.61% | Dec 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $29 → $27 | Strong Buy | Maintains | $29 → $27 | -4.59% | Nov 18, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $28 → $31 | Strong Buy | Maintains | $28 → $31 | +9.54% | Nov 13, 2024 |
Financial Forecast
Revenue This Year
109.24M
from 143.27M
Decreased by -23.75%
Revenue Next Year
98.02M
from 109.24M
Decreased by -10.27%
EPS This Year
-0.81
from -1.52
EPS Next Year
-0.21
from -0.81
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 118.3M | 106.6M | 157.4M | |||
| Avg | 109.2M | 98.0M | 125.3M | |||
| Low | 80.1M | 89.9M | 105.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -17.4% | -2.4% | 60.6% | |||
| Avg | -23.8% | -10.3% | 27.8% | |||
| Low | -44.1% | -17.7% | 7.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.83 | -0.03 | 0.19 |
| Avg | -0.81 | -0.21 | 0.07 |
| Low | -0.78 | -0.40 | -0.12 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.